Advanced search
1 file | 258.38 KB Add to list

Urgent chemotherapy in hematological patients in the ICU

Author
Organization
Abstract
Purpose of review : Over the past decades, survival of critically ill hematological patients has dramatically improved, and these patients are more frequently referred to the ICU for intensive treatment, including a rising need for administering anticancer-therapy in this setting. Recent findings : The scarce literature on this subject provides evidence for feasibility of administering chemotherapy in the ICU, with expected ICU survival of 60-70%, and one in three patients surviving at least 1 year after discharge. We summarize the recent evidence concerning outcome, dosing and indications of chemotherapy in the ICU, and provide practical guidelines for some special oncological situations. Summary : Anticancer-therapy in the ICU is feasible and no longer futile as long as it is initiated in a selected, well-informed patient population with reasonable prognostic expectations. Accurate recognition of organ failure and early referral to the ICU for both supportive care and timely administration of chemotherapy is recommended before the development of multisystem organ failure.
Keywords
hematology, PROGNOSTIC-FACTORS, chemotherapy, intensive care, CRITICALLY-ILL PATIENTS, ACUTE PROMYELOCYTIC LEUKEMIA, ACUTE MONOCYTIC LEUKEMIA, ACUTE MYELOID-LEUKEMIA, INTENSIVE-CARE-UNIT, TUMOR LYSIS SYNDROME, HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, ONCO-HEMATOLOGIQUE, PROSPECTIVE MULTICENTER

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 258.38 KB

Citation

Please use this url to cite or link to this publication:

MLA
Moors, Ine et al. “Urgent Chemotherapy in Hematological Patients in the ICU.” CURRENT OPINION IN CRITICAL CARE 21.6 (2015): 559–568. Print.
APA
Moors, I., Pène, F., Lengline, É., & Benoit, D. (2015). Urgent chemotherapy in hematological patients in the ICU. CURRENT OPINION IN CRITICAL CARE, 21(6), 559–568.
Chicago author-date
Moors, Ine, Frédéric Pène, Étienne Lengline, and Dominique Benoit. 2015. “Urgent Chemotherapy in Hematological Patients in the ICU.” Current Opinion in Critical Care 21 (6): 559–568.
Chicago author-date (all authors)
Moors, Ine, Frédéric Pène, Étienne Lengline, and Dominique Benoit. 2015. “Urgent Chemotherapy in Hematological Patients in the ICU.” Current Opinion in Critical Care 21 (6): 559–568.
Vancouver
1.
Moors I, Pène F, Lengline É, Benoit D. Urgent chemotherapy in hematological patients in the ICU. CURRENT OPINION IN CRITICAL CARE. 2015;21(6):559–68.
IEEE
[1]
I. Moors, F. Pène, É. Lengline, and D. Benoit, “Urgent chemotherapy in hematological patients in the ICU,” CURRENT OPINION IN CRITICAL CARE, vol. 21, no. 6, pp. 559–568, 2015.
@article{7208880,
  abstract     = {{Purpose of review : Over the past decades, survival of critically ill hematological patients has dramatically improved, and these patients are more frequently referred to the ICU for intensive treatment, including a rising need for administering anticancer-therapy in this setting. 
Recent findings : The scarce literature on this subject provides evidence for feasibility of administering chemotherapy in the ICU, with expected ICU survival of 60-70%, and one in three patients surviving at least 1 year after discharge. We summarize the recent evidence concerning outcome, dosing and indications of chemotherapy in the ICU, and provide practical guidelines for some special oncological situations. 
Summary : Anticancer-therapy in the ICU is feasible and no longer futile as long as it is initiated in a selected, well-informed patient population with reasonable prognostic expectations. Accurate recognition of organ failure and early referral to the ICU for both supportive care and timely administration of chemotherapy is recommended before the development of multisystem organ failure.}},
  author       = {{Moors, Ine and Pène, Frédéric and Lengline, Étienne and Benoit, Dominique}},
  issn         = {{1070-5295}},
  journal      = {{CURRENT OPINION IN CRITICAL CARE}},
  keywords     = {{hematology,PROGNOSTIC-FACTORS,chemotherapy,intensive care,CRITICALLY-ILL PATIENTS,ACUTE PROMYELOCYTIC LEUKEMIA,ACUTE MONOCYTIC LEUKEMIA,ACUTE MYELOID-LEUKEMIA,INTENSIVE-CARE-UNIT,TUMOR LYSIS SYNDROME,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,ONCO-HEMATOLOGIQUE,PROSPECTIVE MULTICENTER}},
  language     = {{eng}},
  number       = {{6}},
  pages        = {{559--568}},
  title        = {{Urgent chemotherapy in hematological patients in the ICU}},
  url          = {{http://dx.doi.org/10.1097/MCC.0000000000000254}},
  volume       = {{21}},
  year         = {{2015}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: